Randomized phase II trial of atovaquone with pyrimethamine or sulfadiazine for treatment of toxoplasmic encephalitis in patients with acquired immunodeficiency syndrome: ACTG 237/ANRS 039 Study. AIDS Clinical Trials Group 237/Agence Nationale de Rec (Q43952836)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Randomized phase II trial of atovaquone with pyrimethamine or sulfadiazine for treatment of toxoplasmic encephalitis in patients with acquired immunodeficiency syndrome: ACTG 237/ANRS 039 Study. AIDS Clinical Trials Group 237/Agence Nationale de Rec |
scientific article |
Statements
1 reference
Randomized phase II trial of atovaquone with pyrimethamine or sulfadiazine for treatment of toxoplasmic encephalitis in patients with acquired immunodeficiency syndrome: ACTG 237/ANRS 039 Study. AIDS Clinical Trials Group 237/Agence Nationale de Rec (English)
1 reference
Benjamin J Luft
1 reference
Catherine Leport
1 reference
Keith Chirgwin
1 reference
Richard Hafner
1 reference
Jack Remington
1 reference
Janet Andersen
1 reference
Elizabeth M Bosler
1 reference
Clemente Roque
1 reference
Natasa Rajicic
1 reference
Vincent McAuliffe
1 reference
Philippe Morlat
1 reference
D T Jayaweera
1 reference
Jean-Louis Vilde
1 reference
1 May 2002
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference